{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:36:40Z","timestamp":1782362200067,"version":"3.54.5"},"reference-count":64,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Thrombotic thrombocytopenic purpura (TTP), a life-threatening thrombotic microangiopathy, is caused by severe deficiency of plasma ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, 13) activity. Pregnancy is found to be frequently associated with the onset of acute TTP. However, how pregnancy or postpartum affects the progression of TTP and how ADAMTS13 may play a role in perinatal outcome are not known. Using CRISPR\/CRISPR-associated protein 9, we generated a novel rat model of TTP by deleting 13 nucleotides in the coding region for ADAMTS13 metalloprotease domain. ADAMTS13-deficient (KO) rats showed barely detectable plasma ADAMTS13 activity, with a significantly increased size of plasma von Willebrand factor (VWF) multimers. The KO rats developed severe spontaneous thrombocytopenia, with a median platelet count of 125 \u00d7 109\/L in heterozygous (Het) rats (P&amp;lt; .0001). Moreover, plasma levels of lactate dehydrogenase, urea nitrogen, and creatinine were significantly elevated in KO rats compared with those in WT (P&amp;lt; .05) and Het (P&amp;lt; .05) rats. Immunohistochemistry revealed the presence of VWF-rich and platelet integrin \u03b23\u2013rich microvascular thrombi in major organ tissues of KO rats but not of WT controls. Unexpectedly, pregnancy or postpartum did not result in worsening thrombocytopenia, but increased the risk of death in the KO females bred with KO male rats. These female rats produced significantly fewer live offsprings than those bred with WT or Het males (P&amp;lt; .05). We conclude that the findings in our novel KO rats recapitulate the features of congenital TTP and underscore the importance of fetal-placental ADAMTS13 in perinatal survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019661","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:30:18Z","timestamp":1774989018000},"page":"3615-3628","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Rat models of thrombotic thrombocytopenic purpura reveal crucial role of placental ADAMTS13 in perinatal survival"],"prefix":"10.1182","volume":"10","author":[{"given":"Quan","family":"Zhang","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0120-9343","authenticated-orcid":false,"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Chai","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-4411","authenticated-orcid":false,"given":"Esteban M.","family":"Dominguez","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Soares","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-5295","authenticated-orcid":false,"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"44","key":"2026052610373417500_bib1","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"issue":"18","key":"2026052610373417500_bib2","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1073\/pnas.192448999","article-title":"A new name in thrombosis, ADAMTS13","volume":"99","author":"Sadler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4-6","key":"2026052610373417500_bib3","first-page":"224","article-title":"Biosynthesis of human von Willebrand factor","volume":"18","author":"Verweij","year":"1988","journal-title":"Haemostasis"},{"issue":"6","key":"2026052610373417500_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0025-6196(12)60522-9","article-title":"von Willebrand factor and the endothelium","volume":"66","author":"Wagner","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"2026052610373417500_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"issue":"9","key":"2026052610373417500_bib6","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"issue":"22","key":"2026052610373417500_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"2026052610373417500_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"issue":"24","key":"2026052610373417500_bib9","first-page":"2993","article-title":"Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura","volume":"141","author":"Halkidis","year":"2023","journal-title":"Blood"},{"issue":"31","key":"2026052610373417500_bib10","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.1512561112","article-title":"High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome","volume":"112","author":"Casina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2026052610373417500_bib11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Eng J Med"},{"issue":"9","key":"2026052610373417500_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"issue":"6855","key":"2026052610373417500_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"2026052610373417500_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of thrombotic microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"2026052610373417500_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"2026052610373417500_bib16","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1111\/jth.12934","article-title":"Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use","volume":"13","author":"Cataland","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026052610373417500_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","journal-title":"Haematologica"},{"issue":"17","key":"2026052610373417500_bib18","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N Engl J Med"},{"key":"2026052610373417500_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-319-08717-7_5","volume-title":"ADAMTS13 Biology and Disease","author":"Fujimura","year":"2015"},{"issue":"1","key":"2026052610373417500_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med"},{"issue":"23","key":"2026052610373417500_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/aob-22-18","article-title":"Animal models for thrombotic thrombocytopenic purpura: a narrative review","volume":"8","author":"Zheng","year":"2023","journal-title":"Ann Blood"},{"issue":"10","key":"2026052610373417500_bib22","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"issue":"19","key":"2026052610373417500_bib23","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-02-486779","article-title":"AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura","volume":"121","author":"Jin","year":"2013","journal-title":"Blood"},{"issue":"25","key":"2026052610373417500_bib24","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"issue":"21","key":"2026052610373417500_bib25","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"key":"2026052610373417500_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/bloodadvances.2016000711","article-title":"Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura","volume":"1","author":"Zheng","year":"2016","journal-title":"Blood Adv"},{"issue":"4","key":"2026052610373417500_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2019.237396","article-title":"Histone-induced thrombotic thrombocytopenic purpura in adamts13 (-\/-) zebrafish depends on von Willebrand factor","volume":"105","author":"Zheng","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"2026052610373417500_bib28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2026052610373417500_bib29","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","article-title":"Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura","volume":"123","author":"Jiang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2026052610373417500_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/bloodadvances.2023011972","article-title":"Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience","volume":"8","author":"Beranger","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"2026052610373417500_bib31","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bjh.19723","article-title":"TTP and pregnancy","volume":"205","author":"Gounder","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"2026052610373417500_bib32","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2026052610373417500_bib33","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/jth.15064","article-title":"Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura","volume":"18","author":"Sakai","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"25","key":"2026052610373417500_bib34","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1056\/NEJMoa2211113","article-title":"Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura","volume":"387","author":"Asmis","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"2026052610373417500_bib35","first-page":"108","article-title":"A simple, robust, and cost-effective method for genotyping small-scale mutations","volume":"2","author":"Zheng","year":"2022","journal-title":"J Clin Transl Pathol"},{"issue":"5","key":"2026052610373417500_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1160\/TH11-05-0337","article-title":"Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura","volume":"106","author":"Li","year":"2011","journal-title":"Thromb Haemost"},{"issue":"11","key":"2026052610373417500_bib37","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/ATVBAHA.118.311407","article-title":"Transfusion of platelets loaded with recombinant ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats-13) is efficacious for inhibiting arterial thrombosis associated with thrombotic thrombocytopenic purpura","volume":"38","author":"Abdelgawwad","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2026052610373417500_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/a-2253-9359","article-title":"ADAMTS13 or caplacizumab reduces the accumulation of neutrophil extracellular traps and thrombus in whole blood of COVID-19 patients under flow","volume":"124","author":"Yada","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"2026052610373417500_bib39","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.jtha.2023.08.016","article-title":"Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function","volume":"21","author":"Barton","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"22","key":"2026052610373417500_bib40","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3390\/jcm12227174","article-title":"Dynamic assessment of plasma von Willebrand factor and ADAMTS13 predicts mortality in hospitalized patients with SARS-CoV-2 infection","volume":"12","author":"Zhang","year":"2023","journal-title":"J Clin Med"},{"issue":"21","key":"2026052610373417500_bib41","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.0801735105","article-title":"Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13","volume":"105","author":"Cao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2026052610373417500_bib42","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2008-08-173021","article-title":"Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy","volume":"113","author":"Laje","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2026052610373417500_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/mt.2008.223","article-title":"Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes","volume":"17","author":"Niiya","year":"2009","journal-title":"Mol Ther"},{"issue":"10","key":"2026052610373417500_bib44","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2023011617","article-title":"Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"8","author":"Yada","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"2026052610373417500_bib45","doi-asserted-by":"crossref","first-page":"102947","DOI":"10.1016\/j.rpth.2025.102947","article-title":"SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis","volume":"9","author":"Zhang","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"13","key":"2026052610373417500_bib46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.2019001040","article-title":"Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy","volume":"134","author":"Zheng","year":"2019","journal-title":"Blood"},{"issue":"6","key":"2026052610373417500_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0033-1333750","article-title":"Thrombotic thrombocytopenic purpura in a 15-year-old female","volume":"225","author":"Dakowicz","year":"2013","journal-title":"Klin Padiatr"},{"issue":"14","key":"2026052610373417500_bib48","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/bloodadvances.2024013265","article-title":"Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy","volume":"8","author":"Dadoun","year":"2024","journal-title":"Blood Adv"},{"issue":"24","key":"2026052610373417500_bib49","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2011-08-374223","article-title":"The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia","volume":"118","author":"Crow","year":"2011","journal-title":"Blood"},{"issue":"18","key":"2026052610373417500_bib50","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2026052610373417500_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jca.21251","article-title":"Novel ADAMTS13 mutations in an obstetric patient with Upshaw-Schulman syndrome","volume":"28","author":"Deal","year":"2013","journal-title":"J Clin Apher"},{"issue":"18","key":"2026052610373417500_bib52","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood-2010-02-271957","article-title":"Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice","volume":"116","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2026052610373417500_bib53","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.jtha.2025.02.009","article-title":"Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibalpha fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2026052610373417500_bib54","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","article-title":"Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site","volume":"114","author":"Raife","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2026052610373417500_bib55","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2026052610373417500_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2003.10.004","article-title":"Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells","volume":"41","author":"Lopez","year":"2004","journal-title":"Semin Hematol"},{"issue":"19","key":"2026052610373417500_bib57","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2013-03-487694","article-title":"Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies","volume":"121","author":"Chapin","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2026052610373417500_bib58","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol"},{"key":"2026052610373417500_bib59","article-title":"Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancy","author":"Tanaka","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2026052610373417500_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jog.12125","article-title":"Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancy","volume":"40","author":"Tanaka","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"2026052610373417500_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5482\/HAMO-14-03-0023","article-title":"Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura","volume":"34","author":"Falter","year":"2014","journal-title":"Hamostaseologie"},{"issue":"6","key":"2026052610373417500_bib62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1399-3038.2008.00828.x","article-title":"Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin","volume":"20","author":"Palmeira","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"2026052610373417500_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.placenta.2011.11.026","article-title":"Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface","volume":"33","author":"Soares","year":"2012","journal-title":"Placenta"},{"issue":"16","key":"2026052610373417500_bib64","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2011-12-399501","article-title":"Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"119","author":"Jian","year":"2012","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3615\/2519833\/blooda_adv-2026-019661-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3615\/2519833\/blooda_adv-2026-019661-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:37:47Z","timestamp":1779806267000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/10\/3615\/567504\/Rat-models-of-thrombotic-thrombocytopenic-purpura"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019661","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,15]]}}}